SYNGENE - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 3.6

📉 SYNGENE shows neutral momentum and improving volume, making it a moderately favorable candidate for intraday trading today.

📈 Optimal Trade Setup

• 💰 Buy Price: ₹645–₹650 (near 50 DMA and support zone)
• 📊 Profit Target: ₹660–₹670 (short-term resistance zone)
• 🛑 Stop Loss: ₹638 (below recent support)

📤 Exit Strategy (If Already Holding)

• 📉 Momentum: RSI at 49.4 and MACD at 2.97 suggest neutral-to-mild bullish momentum — hold if price sustains above ₹650
• 📊 Volume: Current volume (4.08L) is above 1-week average (3.54L) — confirms rising intraday interest
• ⏱️ Exit Timing: Consider exiting near ₹670 if price stalls or RSI crosses 60; exit below ₹638 if weakness appears

✅ Positive

• 📈 ROCE (12.8%) and ROE (9.78%) — decent operational efficiency
• 📊 EPS of ₹11.6 and low debt-to-equity ratio (0.07)
• 📈 Price trading near 50 DMA — potential for technical bounce
• 📈 DII holding increased (+0.57%) — domestic institutional support

⚠️ Limitation

• 📉 PEG ratio of 43.4 — expensive growth valuation
• 📉 Price trading below 200 DMA — long-term bearish trend
• 📉 RSI below 50 — momentum not yet confirmed

🚫 Company Negative News

• 📉 Decline in FII holding (-0.20%) — slight foreign investor caution
• 📉 PAT dropped from ₹174 Cr. to ₹74 Cr. QoQ — earnings contraction

📢 Company Positive News

• 📈 Qtr Profit Var: +48.1% — sequential improvement
• 📈 Price recovery from ₹599 to ₹650 — technical bounce from lows

🏭 Industry

• 🧪 Operates in biotechnology and contract research — high-growth but volatile sector
• 📊 Industry PE of 39.3 — SYNGENE trades at a premium

🧾 Conclusion

• ⚖️ SYNGENE is a moderately strong intraday candidate today with improving volume and technical support
• 📉 Avoid aggressive trades unless price action improves with momentum confirmation
• 📊 Suitable for short-term scalping near support zones with tight stop-loss

I can also help you compare SYNGENE with other biotech stocks showing stronger RSI and MACD alignment for intraday setups.